DelveInsight’s “Catheter-Related Bloodstream Infection (CRBSI) Market Insights, Epidemiology, and Market Forecast 2032” report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Catheter-Related Bloodstream Infection Market size, share, and trends in the seven major market (7MM) (i.e., the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).
The Catheter-Related Bloodstream Infection market report covers emerging drugs, current treatment practices, market share of the individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market.
Catheter-Related Bloodstream Infection (CRBSI): An Overview
CRBSI refers to bloodstream infection attributed to an intravascular catheter by quantitative culture of the catheter tip or by differences in growth between catheter and peripheral venipuncture blood culture specimens. Also known as catheter-related sepsis, it is the most common cause of nosocomial bacteremia. CRBSI occurs due to organisms like coagulase-negative staphylococcus, Staphylococcus aureus, enteric gram-negative bacilli, enterococci, streptococci Pseudomonas, and others.
Different measures are used to reduce the risk of occurrence of CRBSI, including the use of utmost barrier, precautions during catheter insertion, effective cutaneous anti-sepsis, and preventive strategies based on inhibiting micro-organisms originating from the skin or catheter hub from adhering to the catheter.
Catheter-Related Bloodstream Infection (CRBSI) Market Key Facts
DelveInsight estimates that the incident population of CRBSI in the 7MM was around 674,347+ in 2020.
The estimates show a higher incidence of CRBSI in the US, with 330,686 cases, in 2020.
Among EU5 countries, Germany accounted for the highest incidence of CRBSI, with 62,368 cases in 2020. Whereas Spain contributed the least number of cases with 16,793 cases.
In 2020, Japan had 140,885 incidence cases and 135,454 diagnosed incidence cases.
As per the analysis, the incidence of Gram-positive bacteria in the US is more than Gram-negative bacteria, and very few are affected by candida species (fungi). Methicillin-susceptible Staphylococcus aureus occupies the maximum patient pool among the Gram-positive bacteria, with 143,072 cases of this category, in 2020.
Among all the 7MM countries, the US accounted for the highest market size of CRBSI, which accounts for approximately 54.93% in 2020.
The market outlook section of the report helps to build a detailed comprehension of the historical, current, and forecasted Catheter-Related Bloodstream Infection market size by analyzing the impact of current and emerging therapies in the market. It also provides a thorough assessment of the market drivers & barriers, unmet needs, and emerging technologies.
The report details the Catheter-Related Bloodstream Infection market trend for each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, mechanism of action (MoA), competition with other therapies, brand value, and their impact on the market.
Catheter-Related Bloodstream Infection (CRBSI) Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of diagnosed patient pool and future trends.
Catheter-Related Bloodstream Infection (CRBSI) Epidemiology Segmentation
Total Incident Population of CRBSI
Total Diagnosed Incident Population of CRBSI
Diagnosed Incidence of CRBSI by Causative Pathogens
Catheter-Related Bloodstream Infection (CRBSI) Drugs Uptake and Pipeline Development Activities
The drug uptake section focuses on the rate of uptake of the potential drugs recently launched in the Catheter-Related Bloodstream Infection market or expected to be launched during the study period. The analysis covers Catheter-Related Bloodstream Infection market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Catheter-Related Bloodstream Infection Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyses recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Request for Sample PDF Report – https://www.delveinsight.com/sample-request/catheter-related-bloodstream-infection-market
Some of the key companies in the Catheter-Related Bloodstream Infection (CRBSI) Market include:
Fresenius Medical Care
And many others
Catheter-Related Bloodstream Infection (CRBSI) Therapies covered in the report include:
And many others.
Get More Detailed Insights Into the Emerging Therapies & Key Companies – https://www.delveinsight.com/sample-request/catheter-related-bloodstream-infection-market
Table of Content (TOC)
1. Key Insights
2. Executive Summary
3. Catheter-Related Bloodstream Infection Competitive Intelligence Analysis
4. Catheter-Related Bloodstream Infection Market Overview at a Glance
5. Catheter-Related Bloodstream Infection Disease Background and Overview
6. Catheter-Related Bloodstream Infection Patient Journey
7. Catheter-Related Bloodstream Infection Epidemiology and Patient Population
8. Catheter-Related Bloodstream Infection Treatment Algorithm, Current Treatment, and Medical Practices
9. Catheter-Related Bloodstream Infection Unmet Needs
10. Key Endpoints of Catheter-Related Bloodstream Infection Treatment
11. Catheter-Related Bloodstream Infection Marketed Products
12. Catheter-Related Bloodstream Infection Emerging Therapies
13. Catheter-Related Bloodstream Infection Seven Major Market Analysis
14. Attribute Analysis
15. Catheter-Related Bloodstream Infection Market Outlook (7 major markets)
16. Catheter-Related Bloodstream Infection Access and Reimbursement Overview
17. KOL Views on the Catheter-Related Bloodstream Infection Market.
18. Catheter-Related Bloodstream Infection Market Drivers
19. Catheter-Related Bloodstream Infection Market Barriers
21. DelveInsight Capabilities
*The Table of Contents (TOC) is not exhaustive; the final content may vary. Refer to the sample report for the complete table of contents.
Download Sample PDF Report – https://www.delveinsight.com/sample-request/catheter-related-bloodstream-infection-market
DelveInsight is a leading Business Consultant and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance.
Other Latest Healthcare Report by DelveInsight
Pulmonology Devices Market
“Pulmonology Devices Market” Research Report provides comprehensive insights into the historical and forecasted Pulmonology Devices Market size, share, trends, and growth estimation. It also covers the latest breakthroughs, collaboration, latest innovations, emerging devices, and key companies working in the global market.
Company Name: DelveInsight Business Research LLP
Contact Person: Anuj Rawat
Email: Send Email
Address:304 S. Jones Blvd #2432
State: New York
Country: United States